ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LGVN Longeveron Inc

1.753
0.063 (3.73%)
Last Updated: 13:20:28
Delayed by 15 minutes

Period:

Draw Mode:

Volume 139,134
Bid Price 1.76
Ask Price 1.77
News -
Day High 1.80

Low
1.60

52 Week Range

High
44.00

Day Low 1.64
Share Name Share Symbol Market Stock Type
Longeveron Inc LGVN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.063 3.73% 1.753 13:20:28
Open Price Low Price High Price Close Price Previous Close
1.67 1.64 1.80 1.69
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
809 139,134 US$ 1.70 US$ 236,810 - 1.60 - 44.00
Last Trade Type Quantity Price Currency
13:23:49 19 US$ 1.76 USD

Longeveron Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 25.13M - 709k -22.21M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Longeveron News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LGVN Message Board. Create One! See More Posts on LGVN Message Board See More Message Board Posts

Historical LGVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.911.921.601.73291,382-0.157-8.22%
1 Month2.875.471.602.596,454,929-1.12-38.92%
3 Months5.305.8581.602.682,330,798-3.55-66.92%
6 Months19.1023.901.603.881,251,293-17.35-90.82%
1 Year27.9044.001.607.91751,343-26.15-93.72%
3 Years61.00450.001.60140.271,822,781-59.25-97.13%
5 Years100.00450.001.60137.821,766,772-98.25-98.25%

Longeveron Description

Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).

Your Recent History

Delayed Upgrade Clock